Follow up patients’ characteristics | 5 Years follow up characteristics (n = 210) | Comparison | Last follow up characteristics (n = 134) | Comparison | |||
---|---|---|---|---|---|---|---|
Mesh | Prolift (n = 94) | Gynemesh (n = 116) | P value | Prolift (n = 52) | Gynemesh (n = 82) | P value | |
Anterior Vaginal Wall prolapse stage (POP-Q), n (%) | 0–1 | 87 (92.5%) | 110 (94.8%) | 0.496 | 49 (94.2%) | 78 (95.1%) | 0.821 |
≥ 2 | 7 (7.4%) | 6 (5.2%) | 3 (5.8%) | 4 (4.9%) | |||
Apical Vaginal Wall prolapse stage (POP-Q), n (%) | 0–1 | 89 (94.7%) | 104 (89.7%) | 0.184 | 50 (96.2%) | 78 (95.1%) | 0.778 |
≥ 2 | 5 (5.3%) | 12 (10.3%) | 2 (3.8%) | 5 (4.9%) | |||
Posterior Vaginal Wall prolapse stage (POP-Q), n (%) | 0–1 | 91 (96.8%) | 111 (95.7%) | 0.674 | 51 (98.1%) | 80 (97.6%) | 0.844 |
≥ 2 | 3 (3.2%) | 5 (4.3%) | 1 (1.9%) | 2 (2.4%) | |||
Repeated POP Surgery, n (%) | 1 (1.1%) | 3 (2.6%) | 0.422 | 2 (3.8%) | 3 (3.7%) | 0.955 | |
Mesh vaginal extrusion, n (%) | 5 (5.3%) | 6 (5.2%) | 0.962 | 5 (9.6%) | 7 (8.5%) | 0.831 | |
Vaginal bleeding, n (%) | 2 (2.1%) | 2 (1.7%) | 0.832 | 3 (5.8%) | 4 (4.9%) | 0.821 | |
Pain#, n (%) | 4 (4.3%) | 7 (6.0%) | 0.565 | 2 (3.8%) | 3 (3.7%) | 0.955 | |
Urinary Incontinence, n (%) | 13 (13.8%) | 11 (9.5%) | 0.325 | 3 (5.8%) | 5 (6.1%) | 0.938 | |
Urinary tract infection, n (%) | 5 (5.3%) | 7 (6.0%) | 0.824 | 3 (5.8%) | 6 (7.3%) | 0.727 | |
Subsequent MUS surgery, n (%) | 5 (5.3%) | 3 (2.6%) | 0.304 | 1 (1.9%) | 3 (3.7%) | 0.565 |